Silence of the Lambs

A die-off of newborn lambs in Australia leads to the discovery of a new toxin and clues to a devastating liver disease in children.

Written byKerry Grens
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

IN TWO SHAKES: Two Australian lambs, one healthy, (right) and one with the biliary atresia-like syndrome (left)STEVE WHITTAKER

In 1988, Peter Windsor, then a veterinary pathologist for the New South Wales Department of Agriculture in Australia, received a call from a field veterinarian about several hundred newborn lambs that had died on a farm in a hilly region of the state near the Burrinjuck Dam. All of the lambs had been producing white feces and died within a few weeks of being born. Windsor asked to examine some of the animals, and upon post-mortem analysis of at least a dozen, “we found they didn’t have any gall bladders and their livers were already starting to develop early signs of cirrhosis,” he says. “This was new to me.”

But the pattern wasn’t entirely new to Australian farmers. In 1964, livestock had suffered a similar ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies